DIFFERENTIATION OF FOCAL NODULAR HYPERPLASIA FROM HEPATOCELLULAR CARCINOMA IN THE NONCIRRHOTIC LIVER WITH A CT-BASED RADIOMICS NOMOGRAM
Keywords:
Focal nodular hyperplasia, Hepatocellular carcinoma, Computer tomography, X-rayAbstract
The main purpose of our study was to develop and validate a radiomics for differentiating focal nodular hyperplasia (FNH) from hepatocellular carcinoma (HCC) in the non-cirrhotic liver before the surgery
References
Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, et al.Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia by CT and MRI. AJR Am J. 2018;211(2):347–57.
Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular liver lesions. Semin Ultrasound CT MR. 2009;30(5):387–407.
Fischer MA, Raptis DA, Donati OF, Hunziker R, Schade E, Sotiropoulos GC, et al. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: multi-center evaluation. Eur J Radiol. 2015;84(10):1879–87.
Virgilio E, Cavallini M. Managing focal nodular hyperplasia of the liver: surgery or minimally-invasive approaches? A review of the preferable treatment options. Anticancer Res. 2018;38(1):33–6.
Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, et al. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: a differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary
phase and focal nodular hyperplasia-like nodules. J Magn Reson Imaging. 2017;45(6):1599–608.
Dioguardi Burgio M, Ronot M, Salvaggio G, Vilgrain V, Brancatelli G. Imaging of hepatic focal nodular hyperplasia: pictorial review and diagnostic strategy. Semin Ultrasound CT MR. 2016;37(6):511–24.
Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6(3):347–62.
Grazioli L, Bondioni MP, Faccioli N, Gambarini S, Tinti R, Schneider G, et al. Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine. J Gastrointest Cancer.
;41(4):221–32.
Yu Y, Lin X, Chen K, Chai W, Hu S, Tang R, et al. Hepatocellular carcinoma and focal nodular hyperplasia of the liver: differentiation with CT spectral imaging. Eur Radiol. 2013;23(6):1660–8.
Boas FE, Kamaya A, Do B, Desser TS, Beaulieu CF, Vasanawala SS, et al. Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans. J Digit Imaging. 2015;28(2):213–23.
Zheng SG, Xu HX, Liu LN, Wang Y, Zhang YF, Guo LH, et al. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization =of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia. Clin Hemorheol Microcirc. 2013;55(3):375–89.
Pei XQ, Liu LZ, Xiong YH, Zou RH, Chen MS, Li AH, et al. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma. Br J Radiol. 2013;86(1023): 20120536.
Zarghampour M, Fouladi DF, Pandey A, Ghasabeh MA, Pandey P, Varzaneh FN, et al. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. J Magn Reson Imaging. 2018;48(4):1080–90.
Onur MR, Cicekci M, Kayali A, Poyraz AK, Kocakoc E. The role of ADCmeasurement in differential diagnosis of focal hepatic lesions. Eur J Radiol. 2012;81(3):e171–6.
Haimerl M, Wächtler M, Platzek I, Müller-Wille R, Niessen C, Hoffstetter P, et al. Added value of Gd-EOB-DTPA-enhanced hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions. BMC Med Imaging
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
